Status:
RECRUITING
Emergency Medical Services (EMS) Telehealth to Speed STEMI Reperfusion
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
The Duke Endowment
Genentech, Inc.
Conditions:
STEMI - ST Elevation Myocardial Infarction
Eligibility:
All Genders
30+ years
Brief Summary
The aim of this study is to evaluate the impact of a Telehealth program on the time from First Medical Contact (FMC) to Reperfusion in STEMI (ST-elevation myocardial infarction) patients, by supportin...
Detailed Description
STEMI (ST-elevation myocardial infarction) is the most severe type of heart attack and carries a 30-day mortality of nearly 8%. Reperfusion therapy is the mainstay of treatment for STEMI, either by pe...
Eligibility Criteria
Inclusion
- All patients calling 9-1-1 in Wilkes County with possible STEMI as determined by the on scene paramedics will be included in the data.
Exclusion
- As this is a Quality Surveillance study, subjects will not be excluded.
Key Trial Info
Start Date :
June 18 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06945900
Start Date
June 18 2025
End Date
December 1 2028
Last Update
June 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157